Loading company…
VitaDAO funds early-stage longevity research through a community-governed model.
VitaDAO supports decentralized drug development by funding early-stage longevity research through a community-owned collective. Members can join by purchasing VITA tokens; the organization had more than 1700 token holders as of 2023. Founded in 2021, it is based in the US. In June 2025, it raised USD 4.1 million in venture funding led by returning investor Pfizer Venture Investments.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in